Heart Diseases

First US FDA Approved Clinical Trial That Tests Gene-Modified Stem Cell Therapy In Congestive Heart Failure patients

By Dr.Ravi at 8 February, 2010, 3:00 am

Today in the history of medical field there are some new recent trials for the benifits of the heart patients are going on. Bioheart, Inc., (OTCBB:BHRT) announced that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). [...]

Read More >>